Cyclacel Pharmaceuticals, Inc. CYCC
6.37 0.00 (+0.00%)
At closeSep 11, 2025, 4:00 PM EDT
6.10 Day range 6.96
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 43.00K | 420.00K | 0 | 0 | 0 | |
| 43.00K | 420.00K | 0 | 0 | 0 | |
| -12.00M | -25.45M | -27.66M | -22.39M | -10.64M | |
| -11.21M | -22.55M | -21.20M | -18.46M | -8.45M | |
| -501.60 | -6,420.00 | -6,888.00 | -7,524.00 | -12,312.00 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 3.14M | 3.38M | 18.34M | 36.56M | 33.41M | |
| 4.09M | 8.80M | 28.05M | 43.14M | 36.80M | |
| 6.27M | 8.20M | 7.62M | 5.44M | 3.54M | |
| -2.17M | 607.00K | 15.94M | 37.69M | 33.26M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -7.99M | -16.11M | -20.83M | -18.54M | -7.93M | |
| 7.82M | 848.00K | 3.00M | 21.74M | 29.50M | |
| -241.00K | -14.97M | -18.21M | 3.15M | 21.52M |